# bit.bio funding rounds and investors

As of 4 Nov 2026, bit.bio has raised $178M across 3 verified rounds on record, plus 2 rounds still being checked; latest: $25 million Series D, announced 4 Nov 2026.

A human cell programming company developing technology to produce consistent, scalable human cell models for drug discovery, disease research, functional genomics and toxicology.

Website: https://bit.bio  
Headquarters: Cambridge, UK  
Page: https://fireround.dev/companies/bit-bio

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-04 | Series D | $25 million | not stated | Jonathan Milner, M&G Investments | [tech.eu](https://tech.eu/2026/11/04/human-cell-programming-company-bitbio-closes-25m-series-d), [businessweekly.co.uk](https://www.businessweekly.co.uk/posts/cambridge-biotech-bitbio-raises-25m-series-d-funding-to-scale-human-cell-models) |
| 2026-01-09 | Series C | US$50 million | M&G Investments | none named | [prnewswire.com](https://www.prnewswire.com/news-releases/mg-champions-uk-innovation-in-drug-discovery-by-leading-us50-million-funding-round-for-biotech-company-bitbio-302657492.html), [finsmes.com](https://www.finsmes.com/2026/01/bit-bio-raises-50m-in-funding.html) |
| 2021-11-05 | Series B | $103 million | not stated | Arch Venture Partners, Charles River Laboratories, Foresite Capital, National Resilience, Inc. (Resilience), Metaplanet, Puhua Capital, Tencent | [bit.bio](https://www.bit.bio/news/first-close-of-series-b-financing), [businesswire.com](https://www.businesswire.com/news/home/20211105005429/en/bit.bio-Raises-in-Excess-of-%24100-Million-in-First-Close-of-Series-B-Financing), [bioindustry.org](https://www.bioindustry.org/resource/bitbio-raises-103-million-in-first-close-of-series-b-financing.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.